Sign inJoin waitlistJoin the waitlist

MB

Michael Brister

Hematology & Oncology · Cmc Department of Medicine Group Pa

Credentials: · ·

History

Clinical Cardiac Electrophysiology
Cooper Medical School of Rowan University/Cooper University Hospital
2023–2025
Hematology and Medical Oncology
Cooper Medical School of Rowan University/Cooper University Hospital
2020–2023
Internal Medicine
2017–2020
Doctor of Medicine
2013–2017

Research

OGlcNAcylation and phosphorylation have opposing structural effects in tau: phosphothreonine induces particular conformational order
Journal of the American Chemical Society · 2014 · First of 4 authors · 75 citations
Unlocking nature's potential: Soursop in the battle against resistant acute myeloid leukemia
Review · Biochemistry and Biophysics Reports · 2025 · 2 citations
A Strategy for Noise Reduction to Improve Patient Experiences With Sleep (SNORES)
American Journal of Medical Quality · 2020 · 1 citations

Tulin Budak-Alpdogan
2 papers
AB
Agata Bielska
1 paper · 1 as a resident
Ananya Nanduri
1 paper · 1 as a fellow
EF
Eitan Frankel
1 paper · 1 as a fellow
FA
Farah Ashraf
1 paper · 1 as a fellow
MM
Merlin Mathew
1 paper · 1 as a resident
Naveen Pemmaraju
1 paper
NU
Neelam Upadhyaya
1 paper · 1 as a fellow
Nicholas Young
1 paper · 1 as a resident
RN
Ritu Nahar
1 paper · 1 as a fellow
Roger Strair
1 paper
SH
Swe Hlaing
1 paper

Clinical trials

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029